Complete Response to Sequential Human Epidermal Growth Factor Receptor 2-Targeted Strategies in a Heavily Pretreated Patient With Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Bladder Cancer

JCO Precis Oncol. 2023 Jan:7:e2200414. doi: 10.1200/PO.22.00414.

Authors

Nildevande F Lima Jr¹, Luana A F Sampaio¹, Camila B Xavier¹, Romulo L Mattedi¹, Marcelo A Queiroz¹, Willian C Nahas^{1

2}, Denis L Jardim^{1

3}

Affiliations

¹ Hospital Sírio-Libanês, São Paulo, Brazil.
² Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
³ Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.

PMID: 36623240
DOI: 10.1200/PO.22.00414

No abstract available

Publication types

Case Reports

MeSH terms

Humans
Receptor, ErbB-2* / metabolism
Urinary Bladder Neoplasms* / drug therapy
Urinary Bladder Neoplasms* / genetics

Substances

ERBB2 protein, human
Receptor, ErbB-2